TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Plasma β-amyloid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Rating Scale for Depression (HAMD-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of spleen stiffness, liver stiffness, or platelets for assessing portal hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Function measure (GMFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-mental state pediatric examination (MMSPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ventricular rate during taVNS application
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dry eye examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal nerve condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sampling of conjunctival sac microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients completing at least 70% of intervention activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Trunk Affect Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMD risk estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scale value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety event free rate
Endpoint domain: Adverse events/effects
Primary endpoint: Failure free rate
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic performance of GlycoScore biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of chronic lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: secondary catheterization owing to urinary retention
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative Leg Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFQ-R14+
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lesion detection ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of bone marrow dysfunction (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of clinically significant infections
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of persistent ICANS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Manual dexterity - Pegboard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual dexterity - Minnesota Rate of Manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand and finger strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cold perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dopamine Transporter Imaging SBR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General health condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General pain condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Pilot Trial Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endoleak classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Safety profile of EUS-GJ
Endpoint domain: Adverse events/effects
Primary endpoint: Change in sibling adjustment to perceptions of disability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive assessment using WISC-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Developmental assessment using Griffiths Mental Development Scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptive behavior assessment using Vineland-II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in estrogen receptor (ER)alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ER beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BrainAGE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BodyAGE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional anisotropy of the cerebellar white matter tracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Psychological Preparedness for Disaster Threats Scale (PPDTS) - Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Disaster Risk Scale for University Students (PDRSUS) - Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time in glycemic range 70-180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in sitting systolic blood pressure (sitSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence of chronic subdural hematoma (cSDH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change from Baseline in Best-Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Care from Children's Point of View
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fall effectiveness scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Urine Protein to Creatinine Ratio (UPCR) at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Estimated Glomerular Filtration Rate (eGFR) Slope Assessed at the Week 48 Interim Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: eGFR Slope Assessed at Study Completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to development of ATTR
Endpoint domain: Mortality/survival
Primary endpoint: Comparison of test scores between ScentAware and UPSIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of CCL18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with grade 3-4 oral mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of inferior dental nerve block vs infiltrative technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of Referral to TUTS or Medication Prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients readmitted to the PHP team
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients readmitted to usual care team
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients readmitted to the PHP team
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients readmitted to usual care team
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Social Determinants of Health
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Stringent Complete Response Rate (sCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of Selinexor plus DRd
Endpoint domain: Adverse events/effects
Primary endpoint: Cutaneous Vascular Conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Use of MOUD
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of PrEP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Urine GAG excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of Interferon (IFN) signalling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency, severity, and seriousness of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of withdrawal from the study
Endpoint domain: Resource use
Primary endpoint: Rates of device use compliance
Endpoint domain: Resource use
Primary endpoint: Reduction in temper outbursts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function assessment by spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Measurement of cardiovascular disease (CVD) markers by measuring blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evaluation of metabolic markers (diabetes) in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Androgen receptor (AR) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of excess weight lost (% EWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence of anatomical anterior vaginal wall prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants Who Experience at Least one Treatment Emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of compliance of MLD breast massage sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: First micturition (hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bladder volume (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Debimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: anesthetic recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal Pressure Gradient Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Sunnybrook facial grading scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: median nerve conduction study
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sleep EEG - quantitative sleep spindles analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Geometric mean of neutralization antibody titre (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence, intensity, duration, and relationship of solicited local and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first composite event (relapse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with antibody titers >= 1:4000 in response to vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with grade 3, 4 or 5 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: success rate of ultrasound-guided ilio-psoas tendon tenotomy technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HIV positive yield of index testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Walking function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Opioid Prescribed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: VOC pattern identification for colorectal cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ability to reach a target posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of the overpressures at the seat/body interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of overpressures bigger for higher pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neutrophil lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: monocyte lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: thrombocyte lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Local field potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NIV usage hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with NIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in blood carbon dioxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximal percentage of change of interferon (IFN-γ) producing mutant-KRAS-specific CD8 and CD4 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postpartum Adaptation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in ACS guideline score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain-related restriction of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of maximum oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oral Mucositis Grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of choosing abstinence or contraception use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in the severity of the sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Acute success rate of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary incontinence-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: modified Rankin Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensorimotor neurological deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clavien Dindo Complication Grading
Endpoint domain: Adverse events/effects
Primary endpoint: Post-PCI physiological results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects Achieving a 50% Reduction in PPPASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of hospitalization associated with COVID-19
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Participants With the Same Gynaecological Conditions at the End of Treatment Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in SARS-CoV-2 positivity in the saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in the SAR-CoV-2 viral load in the saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Completion of a Chest CT Scan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in Glycated hemoglobin (HbA1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in mean fasting blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in 2 hours post meal blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants with asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of participants with difficult-to-treat asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of participants with severe asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time on Treatment (ToT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity of the screening evaluation of the Neocam test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the screening evaluation of the Neocam test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the screening evaluation of the standard test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the screening evaluation of the standard test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium Rate
Endpoint domain: Adverse events/effects
Primary endpoint: ADL using selected RMTs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical Dementia Rating (CDR) scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Altoida, Inc. Neuro Motor Index (NMI) medical device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of children admitted with a diagnosis of probable and confirmed meningitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of children admitted with a diagnosis of severe malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of deaths in children by gender
Endpoint domain: Mortality/survival
Primary endpoint: Anastomotic perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Whole Body Effective Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binary Poor Outcome on the mRS
Endpoint domain: Mortality/survival
Primary endpoint: Composite of various aspects of fluid therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level assessed using CRIES scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-invasive nontyphoidal Salmonella (iNTS) serotype specific immunoglobulin G (IgG) geometric mean concentrations (GMCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of adult participants with solicited administration site events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of infant participants with unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: AFS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of study-eligible subjects
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Speech perception in spatially separated noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact Heat Evoked Potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from major adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Coping levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of Participants Screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility as assessed by percent of sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality as assessed by percent of CHW visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Engagement as assessed by number of follow-up visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Incidence of Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Major adverse cardiovascular and cerebrovascular events (MACCEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in PTSD Related Stigma
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Trauma-related cognitions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Self-reported arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Stress management strategy use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Physiological arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers for TRALI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall minutes of exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes